Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Neostem, Inc. (NBS)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: NBS
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Comments on NBS
NeoStem Closes China Biopharma Acquisition to Boost Revenues
[View article]
Dr. Robin Smith deserves all the credit for her tirelless effort in this transaction. NeoStem will be an important company as next...
More »
Comment by
stan wunderlich
Nov 3 08:51 am
|
Rating:
0
0
China Biotech Week in Review: Cross-Border Deals
[View article]
China Stocks are great.-There is a Super Stock in America,CVM LIKE Dendreon which went from a few $ Stock to $27.- plus, CVM got a Big...
More »
Comment by
gretel
Oct 12 00:32 am
|
Rating:
+2
0
NeoStem Moves Ahead with China Biopharma Acquisition
[View article]
This is great information; we need more people in this arena on Stem Cells. There is a new product out for everyone today; Stem Cells...
More »
Comment by
ray mumme
Oct 9 12:55 pm
|
Rating:
0
0
32 Stem Cell Companies to Watch
[View article]
Great Article, Interesting piece at http://www.worldmarketmedia.com/779/section.aspx/353 Talks about how Obama latest talks are...
More »
Comment by
World Market Media
Sep 16 10:23 am
|
Rating:
0
0
NeoStem Makes Good on China Medical Tourism Initiative with Stem Cell Deal
[View article]
This is very positive. I knew a guy who went to India for Stem cell research and I am not sure of the exact kind of reserarch but he was...
More »
Comment by
User 470851
Aug 13 00:17 am
|
Rating:
0
0
China Biotech in Review: New Developments
[View article]
In other words, Pfizer can't invent any new drugs so they're taking on partnerships with those who can.
Comment by
a. palmer jr.
Jun 22 11:27 am
|
Rating:
0
0
NeoStem: Pro-Active Research Initiates Coverage with Speculative Buy
[View article]
eli, No -- just waiting for them to finalize NDA filing for pixantrone by the end of June as they have guided. Mike On Jun 05 04:27...
More »
Comment by
Mike Havrilla
Jun 5 16:31 pm
|
Rating:
0
0
NeoStem: Pro-Active Research Initiates Coverage with Speculative Buy
[View article]
Hey Mike, do you have new info about CTIC?
Comment by
eli09
Jun 5 16:27 pm
|
Rating:
0
0
Stem Cell Index Surges in Past Week
[View article]
ACTC it's true does have a great depth of talent and patents. The books could be better. I'm going to watch this little star.
Comment by
culliganpro
Jun 4 21:31 pm
|
Rating:
0
0
Stem Cell Index Surges in Past Week
[View article]
Agree with post but, for clarity purposes, Michael West left GERON years ago...he's now CEO at ticker: BTIM On May 11 07:20 AM...
More »
Comment by
overseaer1
May 11 08:00 am
|
Rating:
0
0
Stem Cell Index Surges in Past Week
[View article]
Dear Seeking Alpha Readers, Advanced Cell Technology (ACTC), will be the biggest stem cell gainer of 2009. They have essentially...
More »
Comment by
MiamiRich
May 11 07:20 am
|
Rating:
+1
0
China Biotech in Review: Deals Dominate
[View article]
any insight on BSPM? looks like a deal
Comment by
Danny Furman
Apr 23 16:05 pm
|
Rating:
0
0
China Biotech in Review: Deals Dominate
[View article]
what about aob
Comment by
Hugh Epstein
Apr 19 20:40 pm
|
Rating:
0
0
NeoStem Raises $11 Million to Increase China Operations
[View article]
MYST.OB is the best bang for the buck of any China stock regardless of exchange. Its growth, profit and partnerships are that...
More »
Comment by
Fenton Cho
Apr 14 19:57 pm
|
Rating:
0
0
Banking on NeoStem
[View article]
HealthShares closed all of their ETFs late last year and the Company has no products on the market at this time. On Apr 13 06:05 PM...
More »
Comment by
Mike Havrilla
Apr 14 05:08 am
|
Rating:
+1
0
1
2
3
Next Page
NeoStem Closes China Biopharma Acquisition to Boost Revenues [View article]
China Biotech Week in Review: Cross-Border Deals [View article]
NeoStem Moves Ahead with China Biopharma Acquisition [View article]
32 Stem Cell Companies to Watch [View article]
NeoStem Makes Good on China Medical Tourism Initiative with Stem Cell Deal [View article]
China Biotech in Review: New Developments [View article]
NeoStem: Pro-Active Research Initiates Coverage with Speculative Buy [View article]
NeoStem: Pro-Active Research Initiates Coverage with Speculative Buy [View article]
Stem Cell Index Surges in Past Week [View article]
Stem Cell Index Surges in Past Week [View article]
Stem Cell Index Surges in Past Week [View article]
China Biotech in Review: Deals Dominate [View article]
China Biotech in Review: Deals Dominate [View article]
NeoStem Raises $11 Million to Increase China Operations [View article]
Banking on NeoStem [View article]